7 A novel flurophore-cyano-carboxylic-Ag microhybrid: Enhanced two photon absorption for two-photon photothermal therapy of HeLa cancer cells by targeting mitochondria.

8 Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression.

9 Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.

10 Targeting mitochondria with Au-Ag@Polydopamine nanoparticles for papillary thyroid cancer therapy.

11 Analysis of the results obtained with a new phytotherapeutic association for LUTS versus control. [corrected].

12 Arthritis disease - the use of complementary therapies.

13 In vitro evaluation of genotoxicity of avocado (Persea americana) fruit and leaf extracts in human peripheral lymphocytes.

14 Expression of diverse midgut serine proteinases in the sericigenous Lepidoptera Antheraea assamensis (Helfer) is influenced by choice of host plant species.

15 Ordering a selected Zn(II), Cu(II), Pd(II) and Co(III) complex compounds. Their separately and combinedly antibacterial therapy and DNA-binding studies.

16 Biological evaluation of rare earth complexes bearing 1H-imidazo[4,5-f]-1,10-phenanthroline moiety as promising anticancer chemotherapeutics

17 A window into the brain: Tools to assess preclinical efficacy of biomaterials-based therapies on central nervous system disorders.

18 Synthetic lethal interaction between oxidative stress response and DNA damage repair in the budding yeast and its application to targeted anticancer therapy.

19 Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.

20 Fabrication of silver seeds and nanoparticle on core-shell Ag@SiO<inf>2</inf> nanohybrids for combined photothermal therapy and bioimaging

21 Determination of the activity of uracil-DNA glycosylase by using two-tailed reverse transcription PCR and gold nanoparticle-mediated silver nanocluster fluorescence: a new method for gene therapy-related enzyme detection

22 Recommendations for Regulating the Environmental Risk of Shedding for Gene Therapy and Oncolytic Viruses in Canada.

23 The development of a time-based nursing information system in dermatology outpatients and day therapy areas.

24 Cholinesterase inhibitors as Alzheimer's therapeutics (Review).

25 Reconsideration of anticholinesterase therapeutic strategies against alzheimer's disease

26 Tumor-Microenvironment-Induced All-in-One Nanoplatform for Multimodal Imaging-Guided Chemical and Photothermal Therapy of Cancer.

27 Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression.

28 Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.

29 Discovery of N-methylpiperazinyl flavones as a novel class of compounds with therapeutic potential against Alzheimer's disease: Synthesis, binding affinity towards amyloid β oligomers (Aβo) and ability to disrupt Aβo-PrP <sup>C</sup> interactions

30 Design, synthesis, and biological activity of TLR7-based compounds for chemotherapy-induced alopecia.

31 Synthesis and biological evaluation of (1,2,4)triazole[4,3-a]pyridine derivatives as potential therapeutic agents for concanavalin A-induced hepatitis.

32 Linker Optimization and Therapeutic Evaluation of Phosphatidylserine-Targeting Zinc Dipicolylamine-based Drug Conjugates.

33 Reprogramming lymphocytes for the treatment of melanoma: From biology to therapy.

34 Therapeutically Effective Controlled Release Formulation of Pirfenidone from Nontoxic Biocompatible Carboxymethyl Pullulan-Poly(vinyl alcohol) Interpenetrating Polymer Networks.

35 Augmentation of the therapeutic efficacy of WEE1 kinase inhibitor AZD1775 by inhibiting the YAP–E2F1–DNA damage response pathway axis

36 A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists.

37 Primary antiphospholipid syndrome during aromatase inhibitors therapy: A case report and review of the literature.

38 Exploring the chemistry and therapeutic potential of triazoles: A comprehensive literature review.

39 Novel design of NIR-triggered plasmonic nanodots capped mesoporous silica nanoparticles loaded with natural capsaicin to inhibition of metastasis of human papillary thyroid carcinoma B-CPAP cells in thyroid cancer chemo-photothermal therapy.

40 Intracellular dark-field imaging of ATP and photothermal therapy using a colorimetric assay based on gold nanoparticle aggregation via tetrazine/trans-cyclooctene cycloaddition.

41 Gold nanoparticle based photothermal therapy: Development and application for effective cancer treatment

42 Synthesis and characterization of gold nanoparticles from aqueous leaf extract of Alternanthera sessilis and its anticancer activity on cervical cancer cells (HeLa)

43 Host–guest chemistry in supramolecular theranostics

44 Regulation of peripheral tert-butyl position: Approaching efficient blue OLEDs based on solution-processable hole-transporting materials

45 Participation of cannabinoid receptors in peripheral nociception induced by some NSAIDs

46 Distinct BOLD Activation Profiles Following Central and Peripheral Oxytocin Administration in Awake Rats.

47 Protective Effect of Carvacrol on Oxidative Stress and Cellular DNA Damage Induced by UVB Irradiation in Human Peripheral Lymphocytes.

48 PEG-derivatized birinapant as a nanomicellar carrier of paclitaxel delivery for cancer therapy.

49 Revealing uninfected and infected target cell dynamics from peripheral blood data in highly and less pathogenic simian/human immunodeficiency virus infected Rhesus macaque.

50 Therapist and clinic effects in psychotherapy: A three-level model of outcome variability.

51 Predictors of Clinical Reasoning Using the Reasoning 4 Change Instrument With Physical Therapist Students.

52 Does the working alliance mediate the effect of routine outcome monitoring (ROM) and alliance feedback on psychotherapy outcomes? A secondary analysis from a randomized clinical trial.

53 Bioactive glasses meet phytotherapeutics: The potential of natural herbal medicines to extend the functionality of bioactive glasses.

54 [Commercial mobile applications in the therapeutic approach to stroke: Review in main application repositories and scientific evidence].

55 Challenges and Contradictions of Metal Nano-Particle Applications for Radio-Sensitivity Enhancement in Cancer Therapy.

56 Laboratory information management software for engineered mini-protein therapeutic workflow.

57 Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimized dosing schedule.

58 Using the Revised Bloom Taxonomy to Analyze Psychotherapeutic Games

59 Severe acute myocardial infarction and peripheral thrombosis in patient with bladder cancer

60 Evaluation of Continuous Renal Replacement Therapy and Therapeutic Plasma Exchange, in Severe Sepsis or Septic Shock in Critically Ill Children.

61 Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish.

62 Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.

63 Capsaicinoids enhance chemosensitivity to chemotherapeutic drugs.

64 Potential Negative Effects of Dextromethorphan as an Add-On Therapy to Methylphenidate in Children With ADHD.

65 Radiotherapy isocenters verified by matching to bony landmarks of the canine and feline head differ when localized using volumetric vs planar imaging.

66 NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim

67 Targeted alpha therapy with bismuth-213 and actinium-225: Meeting future demand.

68 Effects of cognitive behavioral therapy on psychological adjustment in Chinese pediatric cancer patients receiving chemotherapy: A randomized trial.

69 Initial Experience of Pembrolizumab Therapy in Japanese Patients With Metastatic Urothelial Cancer.

70 Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief

71 Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies

72 Cost-effectiveness of direct anti-viral agents for hepatitis C virus infection and a combined intervention of syringe access and medication assisted therapy for opioid use disorders in an injection drug use population.

73 TCPro: an In Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity.

74 Towards Enhancing Therapeutic Glycoprotein Bioproduction: Interventions in the PI3K/AKT/mTOR Pathway.

75 How should therapeutic decisions about expensive drugs be made in imperfect environments?

76 A Novel ZnO Nanoparticle as Drug Nanocarrier in Therapeutic applications: Kinetic Models and Error Analysis

77 A Novel ZnO Nanoparticle as Drug Nanocarrier in Therapeutic applications: Kinetic Models and Error Analysis

78 Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy

79 Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: challenges and future prospects.

80 Clinical mycology in Latin America and the Caribbean: A snapshot of diagnostic and therapeutic capabilities

81 Testing the role of vitamin D in response to antitumour necrosis factor α therapy in a UK cohort: a Mendelian randomisation approach.

82 Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.

83 Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.

84 Thromboembolic, Bleeding, and Mortality Risks among Patients with Nonvalvular Atrial Fibrillation Treated with Dual Antiplatelet Therapy versus Oral Anticoagulants: A Population-Based Study.

85 Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy.

86 Economic evaluation of the use of non-Vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: A modelling analysis using the healthcare system in the Netherlands

87 Outcomes of intraparenchymal hemorrhage after direct oral anticoagulant or vitamin K antagonist therapy: A systematic review and meta-analysis

88 Multivariate relationships between international normalized ratio and vitamin K-dependent coagulation-derived parameters in normal healthy donors and oral anticoagulant therapy patients

89 The Effect of Vacuum-Assisted Closure Therapy on Methicillin-Resistant Staphylococcus aureus Wound Biofilms.

90 Pharmacological Properties of the Medical Maggot: A Novel Therapy Overview.

91 Low-level laser therapy as an antimicrobial and antibiofilm technology and its relevance to wound healing

92 Harnessing electrical energy for anti-biofilm therapies: effects of current on cell morphology and motility

93 Alternanthera reineckii Briq.’nin doku kültürü çalışmaları için yüzey sterilizasyonunun optimizasyonu

94 New modalities of cancer treatment for NSCLC: focus on immunotherapy

95 Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy

96 Outcomes of therapeutic keratoplasty for severe infectious keratitis in Chongqing, a 16-year experience

97 Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: clinical outcomes, impacts of sex and menses

98 A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea

99 Staphyloxanthin: a potential target for antivirulence therapy

100 Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

101 In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

Keyword Connections

Journals

Research Groups

Bibliographies